Add BrightSurf on Google Email

Science News for June 12, 2003


SARS death rate lower in countries responding aggressively to initial outbreak

Researchers analyzed data from the World Health Organization and found that countries with quicker control measures had lower fatality rates and slower epidemics. The study suggests that better control measures, such as rapid hospitalization and isolation of cases, are more effective than differences in infectivity or virulence.

SourceUniversity of California - Berkeley·JournalEmerging Infectious Diseases·DateJun 12, 2003

IV infustions of human umbilical cord blood stem cells benefit rodents with ALS, spinal cord injury

Researchers found that intravenous infusions of human umbilical cord blood stem cells delayed ALS disease progression by at least two to three weeks and improved survival in mice. The cells also circulated to organs outside the central nervous system, suggesting an immune-protective mechanism.

SourceUniversity of South Florida (USF Health)·JournalJournal of Hematotherapy & Stem Cell Research·DateJun 12, 2003

A different antiviral for treating SARS

Researchers at Frankfurt University Medical School have assessed the antiviral potential of five drugs against the SARS coronavirus. Glycyrrhizin, an antiviral agent proven to treat HIV-1 and hepatitis C, is the most active compound in inhibiting replication, with increased nitric oxide synthesis contributing to its effectiveness.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 12, 2003

Changing global nitrogen cycle impacting human health, says Colorado University-led study

A recent study by Colorado University-led researchers highlights the growing health risks associated with changes in the global nitrogen cycle. The excessive use of nitrogen fertilizers has led to increased crop production in poor nations but poses significant environmental and health concerns for humans worldwide.

SourceUniversity of Colorado at Boulder·JournalFrontiers in Ecology and the Environment·DateJun 12, 2003

The Plasti-Bone

Acer's process creates a micro-porous calcium phosphate coated polymer 'bone' that allows natural bone growth, reducing recovery time to 18 months. The technology, funded by the Navy Small Business Technology Transition program, has shown success in animal testing and tissue cultures.

Study finds statins would cut heart attacks and strokes by a third in people with diabetes

A UK multi-centre randomised trial found that statins reduce the risk of heart attacks, strokes or revascularisation operations by about a third in diabetic patients, irrespective of their cholesterol levels. This could prevent at least 10,000 heart attacks, strokes and revascularisation operations each year worldwide.